Login
Home
Charts
Search
Watchlist
Products

Sumitomo Chemical India Ltd

SUMICHEM·NSE
457.50+0.65%Tue, 22 Sept '26 15:58

Sumitomo Chemical India Ltd

SUMICHEM
NSE
457.50
+0.65%
|Tue, 22 Sept '26 15:58
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
22,936Cr
Close
Close Price
459.50
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
39.58
PS
Price To Sales
7.07
Revenue
Revenue
3,245Cr
Rev Gr TTM
Revenue Growth TTM
-3.61%
PAT Gr TTM
PAT Growth TTM
3.86%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
9035426748399886426791,0579305686841,063
Growth YoY
Revenue Growth YoY%
-19.4-28.03.515.89.418.40.826.0-5.9-11.50.60.6
Expenses
ExpensesCr
716476534678743536560838712468550830
Operating Profit
Operating ProfitCr
1886614016124510612021921899134233
OPM
OPM%
20.812.120.819.224.816.517.620.723.417.519.621.9
Other Income
Other IncomeCr
252727263131323939213274
Interest Expense
Interest ExpenseCr
111112222222
Depreciation
DepreciationCr
161617151619161617171717
PBT
PBTCr
19575149171260117133241238102148288
Tax
TaxCr
522139446729336360263674
PAT
PATCr
143551101271938710017817876111215
Growth YoY
PAT Growth YoY%
-28.8-39.552.4105.434.259.8-9.240.6-7.7-13.311.620.4
NPM
NPM%
15.910.116.315.119.513.614.716.919.113.316.320.2
EPS
EPS
2.91.12.22.53.91.72.03.63.61.52.24.3
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
9035426748399886426791,0579305686841,063
Growth YoY
Revenue Growth YoY%
-19.4-28.03.515.89.418.40.826.0-5.9-11.50.60.6
Expenses
ExpensesCr
716476534678743536560838712468550830
Operating Profit
Operating ProfitCr
1886614016124510612021921899134233
OPM
OPM%
20.812.120.819.224.816.517.620.723.417.519.621.9
Other Income
Other IncomeCr
252727263131323939213274
Interest Expense
Interest ExpenseCr
111112222222
Depreciation
DepreciationCr
161617151619161617171717
PBT
PBTCr
19575149171260117133241238102148288
Tax
TaxCr
522139446729336360263674
PAT
PATCr
143551101271938710017817876111215
Growth YoY
PAT Growth YoY%
-28.8-39.552.4105.434.259.8-9.240.6-7.7-13.311.620.4
NPM
NPM%
15.910.116.315.119.513.614.716.919.113.316.320.2
EPS
EPS
2.91.12.22.53.91.72.03.63.61.52.24.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,9132,2122,4252,6453,0613,5112,8443,1493,2383,245
Growth
Revenue Growth%
15.69.69.115.714.7-19.010.72.9-3.6
Expenses
ExpensesCr
1,6961,9482,0922,1582,4612,8442,3692,5162,5672,560
Operating Profit
Operating ProfitCr
217264333487600667475632671685
OPM
OPM%
11.311.913.718.419.619.016.720.120.721.1
Other Income
Other IncomeCr
3028-2019274596120131166
Interest Expense
Interest ExpenseCr
3466655688
Depreciation
DepreciationCr
24284147455262666668
PBT
PBTCr
221260267453576654503680728775
Tax
TaxCr
769462108152152133174185196
PAT
PATCr
145166205345424502370506543579
Growth
PAT Growth%
14.323.568.722.618.6-26.437.07.23.9
NPM
NPM%
7.67.58.413.113.814.313.016.116.817.9
EPS
EPS
2.93.34.16.98.510.17.410.110.911.6
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,9132,2122,4252,6453,0613,5112,8443,1493,2383,245
Growth
Revenue Growth%
15.69.69.115.714.7-19.010.72.9-3.6
Expenses
ExpensesCr
1,6961,9482,0922,1582,4612,8442,3692,5162,5672,560
Operating Profit
Operating ProfitCr
217264333487600667475632671685
OPM
OPM%
11.311.913.718.419.619.016.720.120.721.1
Other Income
Other IncomeCr
3028-2019274596120131166
Interest Expense
Interest ExpenseCr
3466655688
Depreciation
DepreciationCr
24284147455262666668
PBT
PBTCr
221260267453576654503680728775
Tax
TaxCr
769462108152152133174185196
PAT
PATCr
145166205345424502370506543579
Growth
PAT Growth%
14.323.568.722.618.6-26.437.07.23.9
NPM
NPM%
7.67.58.413.113.814.313.016.116.817.9
EPS
EPS
2.93.34.16.98.510.17.410.110.911.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
275275499499499499499499499
Reserves
ReservesCr
6797747231,0421,4281,8831,9422,4022,891
Current Liabilities
Current LiabilitiesCr
6727768401,0811,021933801965970
Non Current Liabilities
Non Current LiabilitiesCr
3335455061546894111
Total Liabilities
Total LiabilitiesCr
1,6581,8602,1062,6723,0103,3693,3133,9644,474
Current Assets
Current AssetsCr
1,3461,5411,7462,3042,5222,7882,6733,0203,340
Non Current Assets
Non Current AssetsCr
3133193613684885816409441,134
Total Assets
Total AssetsCr
1,6581,8602,1062,6723,0103,3693,3133,9644,474
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
275275499499499499499499499
Reserves
ReservesCr
6797747231,0421,4281,8831,9422,4022,891
Current Liabilities
Current LiabilitiesCr
6727768401,0811,021933801965970
Non Current Liabilities
Non Current LiabilitiesCr
3335455061546894111
Total Liabilities
Total LiabilitiesCr
1,6581,8602,1062,6723,0103,3693,3133,9644,474
Current Assets
Current AssetsCr
1,3461,5411,7462,3042,5222,7882,6733,0203,340
Non Current Assets
Non Current AssetsCr
3133193613684885816409441,134
Total Assets
Total AssetsCr
1,6581,8602,1062,6723,0103,3693,3133,9644,474

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4778221425222389757452446
Investing Cash Flow
Investing Cash FlowCr
-40-35-118-283-290-327-420-392-332
Financing Cash Flow
Financing Cash FlowCr
7-65-61-47-63-73-337-68-83
Net Cash Flow
Net Cash FlowCr
15-234296-131-100-831
Free Cash Flow
Free Cash FlowCr
439184383109270695423403
CFO To PAT
CFO To PAT%
32.746.9108.2123.252.477.5204.889.282.0
CFO To EBITDA
CFO To EBITDA%
21.929.566.587.437.058.4159.671.466.4
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
4778221425222389757452446
Investing Cash Flow
Investing Cash FlowCr
-40-35-118-283-290-327-420-392-332
Financing Cash Flow
Financing Cash FlowCr
7-65-61-47-63-73-337-68-83
Net Cash Flow
Net Cash FlowCr
15-234296-131-100-831
Free Cash Flow
Free Cash FlowCr
439184383109270695423403
CFO To PAT
CFO To PAT%
32.746.9108.2123.252.477.5204.889.282.0
CFO To EBITDA
CFO To EBITDA%
21.929.566.587.437.058.4159.671.466.4

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9,15714,51522,43921,22617,34027,89018,20422,936
Price To Earnings
Price To Earnings
44.742.053.042.347.055.233.539.6
Price To Sales
Price To Sales
3.85.57.36.06.18.95.67.1
Price To Book
Price To Book
7.59.411.68.97.19.65.46.8
EV To EBITDA
EV To EBITDA
27.329.437.331.436.244.127.133.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
31.130.330.134.234.532.533.536.837.837.8
OPM
OPM%
11.311.913.718.419.619.016.720.120.721.1
NPM
NPM%
7.67.58.413.113.814.313.016.116.817.9
ROCE
ROCE%
23.224.721.629.229.627.320.623.221.321.3
ROE
ROE%
15.215.816.822.422.021.115.117.516.016.0
ROA
ROA%
8.88.99.712.914.114.911.212.812.112.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9,15714,51522,43921,22617,34027,89018,20422,936
Price To Earnings
Price To Earnings
44.742.053.042.347.055.233.539.6
Price To Sales
Price To Sales
3.85.57.36.06.18.95.67.1
Price To Book
Price To Book
7.59.411.68.97.19.65.46.8
EV To EBITDA
EV To EBITDA
27.329.437.331.436.244.127.133.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
31.130.330.134.234.532.533.536.837.837.8
OPM
OPM%
11.311.913.718.419.619.016.720.120.721.1
NPM
NPM%
7.67.58.413.113.814.313.016.116.817.9
ROCE
ROCE%
23.224.721.629.229.627.320.623.221.321.3
ROE
ROE%
15.215.816.822.422.021.115.117.516.016.0
ROA
ROA%
8.88.99.712.914.114.911.212.812.112.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Sumitomo Chemical India Ltd

  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/stiojavvrh5l4bq4kf1ybzas.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/xsvn80pe22j4sw4ql6a0e0x4.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/ybg4ka5ov7qm0af1knzwwbet.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/e80izwecxerx1rehi5kmprga.pdf
  • Q4 FY2024 Earnings Call Transcript (Mar 2024, PDF): https://www.stockscans.in/document/3nveoaepey5foynmucm1onmf.pdf
  • Q2 FY2024 Earnings Call Transcript (Sep 2023, PDF): https://www.stockscans.in/document/0u5m34qv1shj2503ti3o7vsy.pdf
  • Q4 FY2023 Earnings Call Transcript (Mar 2023, PDF): https://www.stockscans.in/document/19xy55ubmdq1et5ul6flw8j2.pdf
  • Q2 FY2023 Earnings Call Transcript (Sep 2022, PDF): https://www.stockscans.in/document/m1y9e50dmk4pcoh837af9c0l.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/ubwlv9x3ly442rvj20fj36ab.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/jc4xosi7z0n45dbhf0igdt7h.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/7b2co1ccb95wzl2lscx3qjhv.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/vzsejdopgovyn5shqnzxt3ye.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/2sgp9fc90qmtznryo9xhydfx.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/xvt4gapz9c64r7whwey7xac0.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/mbt9grtvrysevpmm5pymycxj.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/sqnw0virt2aemc1i8k34qlio.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/k8jlxyu3yn44trkivcyhr1j4.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/wfxoc6svr1e8r0qehnrfvmx8.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/utkn61zu8a33xat8e4lrwsac.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/arbohkkjsb5ogz06erj244ds.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/p4sxp6qjgclxg1dn90jww70d.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/ozpebb09ym9zizbp0ekk0dsl.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/b4zv90zew034llw7yay8hl51.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/qytj6yje0ruyh32liysxl8ph.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/34vcbpd5r4tzzyevaecl3cg2.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/hqkvpkh167mcxj57h7pqe4i7.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/nk9wjnyl2kywln34ncxyldsn.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/3ywh9s3tpe4vypgil2dbl7ww.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/fe958b74r0ghykpfsl54d9pa.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/hpmjzryxjcyji75jdmqpcaib.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/sh1dkpb3ms9c8cuy1iklub7j.pdf

Concall Transcript Summaries — Sumitomo Chemical India Ltd

  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ASUMICHEM/transcript-notes/202603/stiojavvrh5l4bq4kf1ybzas.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ASUMICHEM/transcript-notes/202509/xsvn80pe22j4sw4ql6a0e0x4.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ASUMICHEM/transcript-notes/202503/ybg4ka5ov7qm0af1knzwwbet.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ASUMICHEM/transcript-notes/202409/e80izwecxerx1rehi5kmprga.pdf
  • Q4 FY2024 Concall Transcript Summary (Mar 2024): https://www.stockscans.in/company/NSE%3ASUMICHEM/transcript-notes/202403/3nveoaepey5foynmucm1onmf.pdf
  • Q2 FY2024 Concall Transcript Summary (Sep 2023): https://www.stockscans.in/company/NSE%3ASUMICHEM/transcript-notes/202309/0u5m34qv1shj2503ti3o7vsy.pdf
  • Q4 FY2023 Concall Transcript Summary (Mar 2023): https://www.stockscans.in/company/NSE%3ASUMICHEM/transcript-notes/202303/19xy55ubmdq1et5ul6flw8j2.pdf
  • Q2 FY2023 Concall Transcript Summary (Sep 2022): https://www.stockscans.in/company/NSE%3ASUMICHEM/transcript-notes/202209/m1y9e50dmk4pcoh837af9c0l.pdf